Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

BACKGROUND: There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). METHODS: We assessed the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:N Engl J Med
Asıl Yazarlar: Reynolds, Harmony R., Adhikari, Samrachana, Pulgarin, Claudia, Troxel, Andrea B., Iturrate, Eduardo, Johnson, Stephen B., Hausvater, Anaïs, Newman, Jonathan D., Berger, Jeffrey S., Bangalore, Sripal, Katz, Stuart D., Fishman, Glenn I., Kunichoff, Dennis, Chen, Yu, Ogedegbe, Gbenga, Hochman, Judith S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Massachusetts Medical Society 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206932/
https://ncbi.nlm.nih.gov/pubmed/32356628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2008975
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller